Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model

[1]  U. Schöffel,et al.  Epidemiology and pathophysiology of intraabdominal infections (IAI) , 1998, Infection.

[2]  R. Bleichrodt,et al.  A peritonitis model with low mortality and persisting intra‐abdominal abscesses , 2006, International journal of experimental pathology.

[3]  D. Leaper,et al.  Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. , 2005, The Cochrane database of systematic reviews.

[4]  J. Bae,et al.  Prevention of Intraperitoneal Adhesions and Abscesses by Polysaccharides Isolated From Phellinus spp in a Rat Peritonitis Model , 2005, Annals of surgery.

[5]  John C. Hall,et al.  Peritoneal mesothelial cells produce cytokines in a murine model of peritonitis. , 2004, Surgical infections.

[6]  D. Collen,et al.  Tissue‐type plasminogen activator: a historical perspective and personal account , 2004, Journal of thrombosis and haemostasis : JTH.

[7]  J. Berkenbosch,et al.  Tissue Plasminogen Activator as an Adjuvant Therapy for Pleural Empyema in Pediatric Patients , 2004, Journal of intensive care medicine.

[8]  Vineeta Singh.  Critical care assessment and management of acute ischemic stroke. , 2004, Journal of vascular and interventional radiology : JVIR.

[9]  T. Gerstle,et al.  Tissue plasminogen activator for the treatment of intraabdominal abscesses in a neonate. , 2003, Journal of pediatric surgery.

[10]  J. Marshall,et al.  Intensive care unit management of intra-abdominal infection , 2003, Critical care medicine.

[11]  H. van Goor,et al.  Pathophysiology of intra‐abdominal adhesion and abscess formation, and the effect of hyaluronan , 2003, The British journal of surgery.

[12]  M. Schein.  Surgical management of intra-abdominal infection: is there any evidence? , 2002, Langenbeck's Archives of Surgery.

[13]  M. Bülbül,et al.  Peritoneal fibrinolytic activity in peritonitis. , 2002, American journal of surgery.

[14]  H. van Goor,et al.  Polyanionic polysaccharides reduce intra-abdominal adhesion and abscess formation in a rat peritonitis model. , 2001, The Journal of surgical research.

[15]  D. Gouma,et al.  IL-10-Deficient Mice Demonstrate Multiple Organ Failure and Increased Mortality During Escherichia coli Peritonitis Despite an Accelerated Bacterial Clearance1 , 2001, The Journal of Immunology.

[16]  J. Tellado,et al.  Defense mechanisms of the peritoneal cavity , 2001, Current opinion in critical care.

[17]  S. Colizza,et al.  Antibiotic Prophylaxis and Treatment of Surgical Abdominal Sepsis , 2001, Journal of chemotherapy.

[18]  P. Watkins,et al.  Experimental models of Gram‐negative sepsis , 2001, The British journal of surgery.

[19]  J. Yee,et al.  Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  G. Beathard.  Catheter Thrombosis , 2001, Seminars in dialysis.

[21]  P. Shek,et al.  Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis , 2000, Critical care medicine.

[22]  C. van der Werken,et al.  Surgical management of severe secondary peritonitis. , 1999, The British journal of surgery.

[23]  J. Mohler,et al.  Microbiological and Inflammatory Effects of Murine Recombinant Interleukin-10 in Two Models of Polymicrobial Peritonitis in Rats , 1999, Infection and Immunity.

[24]  B. Risberg,et al.  Plasminogen activators and inhibitors in peritoneal tissue , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[25]  L. Holmdahl.  The role of fibrinolysis in adhesion formation. , 1997, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[26]  J. van der Meer,et al.  Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model. , 1996, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[27]  B. Risberg,et al.  Fibrinolysis in human peritoneum during operation. , 1996, Surgery.

[28]  H. van Goor,et al.  Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator. , 1995, Journal of the American College of Surgeons.

[29]  J. van der Meer,et al.  Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis. , 1994, Journal of the American College of Surgeons.

[30]  J. Thompson,et al.  Effect of experimental peritonitis and ischaemia on peritoneal fibrinolytic activity. , 1994, The European journal of surgery = Acta chirurgica.

[31]  C. Visser,et al.  Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  O. Rotstein,et al.  Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator. , 1988, The Journal of infectious diseases.

[33]  T. Simon.  Thrombolytic Therapy in Pulmonary Embolism , 1977, Vascular surgery.